The Food and Drug Administration (FDA) conducted an inspection at Parkland Health and Hospital Services System in Dallas on April 9, reviewing procedures related to blood and blood products, data from the FDA’s website shows.
The inspection concluded that no corrective action was required regarding Parkland Health and Hospital Services System’s operational management.
Across the country, the FDA regularly examines sites to confirm their compliance with federal regulations designed to protect public health. Inspection outcomes are made available to the public.
The FDA’s website describes the agency as the primary regulator overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco goods.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
